ORAL VACCINES USE

Brand Owner (click to sort) Address Description
VAAST VAXART, INC. 170 Harbor Way, Suite 300 South San Francisco CA 94080 ORAL VACCINES FOR USE IN HUMANS;
VAXART VAXART, INC. 170 Harbor Way, Suite 300 South San Francisco CA 94080 ORAL VACCINES FOR USE IN HUMANS;VACCINES ART;
VAXART VAXART, INC. 170 Harbor Way, Suite 300 South San Francisco CA 94080 ORAL VACCINES FOR USE IN HUMANS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention involves a papilloma pseudovirus that can induce immune response after oral intake as well as its preparation. It is characterized in that HPV or BPV pseudovirus are made by disrupting HPV-VLP or BPV-VLP, mixing them with plasmids (plasmids or DNA vaccine), and reassembling them into the pseudoviruses (VLPs with plasmids inside). Oral administration of the pseudoviruses will result in delivery to mucosal and systemic lymphoid tissues and induce immune responses for disease prevention and treatment. The pseudovirus induces stronger immune response than DNA vaccines. Additionally, the pseudovirus can be applied in gene therapy by bringing the therapeutic genes into lymphoid tissues in the human body.